Æȷοì
Han Sang Kim
Han Sang Kim
Medical Oncology, Internal Medicine, Yonsei University College of Medicine, Yonsei Cancer Center
yuhs.acÀÇ À̸ÞÀÏ È®ÀεÊ
Á¦¸ñ
Àοë
Àοë
¿¬µµ
Extracellular vesicles in cancer: cell-to-cell mediators of metastasis
A Becker, BK Thakur, JM Weiss, HS Kim, H Peinado, D Lyden
Cancer cell 30 (6), 836-848, 2016
18572016
Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation
H Zhang, D Freitas, HS Kim, K Fabijanic, Z Li, H Chen, MT Mark, H Molina, ...
Nature cell biology 20 (3), 332-343, 2018
15502018
Extracellular vesicle and particle biomarkers define multiple human cancers
A Hoshino, HS Kim, L Bojmar, KE Gyan, M Cioffi, J Hernandez, ...
Cell 182 (4), 1044-1061. e18, 2020
9882020
Tumour exosomal CEMIP protein promotes cancer cell colonization in brain metastasis
G Rodrigues, A Hoshino, CM Kenific, IR Matei, L Steiner, D Freitas, ...
Nature cell biology 21 (11), 1403-1412, 2019
3592019
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
S Qin, SL Chan, S Gu, Y Bai, Z Ren, X Lin, Z Chen, W Jia, Y Jin, Y Guo, ...
The Lancet 402 (10408), 1133-1146, 2023
3312023
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
JM Llovet, M Kudo, P Merle, T Meyer, S Qin, M Ikeda, R Xu, J Edeline, ...
The Lancet Oncology 24 (12), 1399-1410, 2023
1852023
Identification of a radiosensitivity signature using integrative metaanalysis of published microarray data for NCI-60 cancer cells
HS Kim, SC Kim, SJ Kim, CH Park, HC Jeung, YB Kim, JB Ahn, HC Chung, ...
BMC genomics 13, 1-10, 2012
1562012
Neopepsee: accurate genome-level prediction of neoantigens by harnessing sequence and amino acid immunogenicity information
S Kim, HS Kim, E Kim, MG Lee, EC Shin, S Paik
Annals of Oncology 29 (4), 1030-1036, 2018
1482018
Tumour extracellular vesicles and particles induce liver metabolic dysfunction
G Wang, J Li, L Bojmar, H Chen, Z Li, GC Tobias, M Hu, EA Homan, ...
Nature 618 (7964), 374-382, 2023
1062023
Oncogenic BRAF fusions in mucosal melanomas activate the MAPK pathway and are sensitive to MEK/PI3K inhibition or MEK/CDK4/6 inhibition
HS Kim, M Jung, HN Kang, H Kim, CW Park, SM Kim, SJ Shin, SH Kim, ...
Oncogene 36 (23), 3334-3345, 2017
982017
Targeting mutant KRAS with CRISPR-Cas9 controls tumor growth
W Kim, S Lee, HS Kim, M Song, YH Cha, YH Kim, J Shin, ES Lee, Y Joo, ...
Genome research 28 (3), 374-382, 2018
912018
Personalized therapy on the horizon for squamous cell carcinoma of the lung
HS Kim, T Mitsudomi, RA Soo, BC Cho
Lung cancer 80 (3), 249-255, 2013
822013
A phase II study of avelumab monotherapy in patients with mismatch repair-deficient/microsatellite instability-high or POLE-mutated metastatic or unresectable colorectal cancer
JH Kim, SY Kim, JY Baek, YJ Cha, JB Ahn, HS Kim, KW Lee, JW Kim, ...
Cancer Res Treat 52 (4), 1135-1144, 2020
792020
Randomized controlled trial of standardized education and telemonitoring for pain in outpatients with advanced solid tumors
HS Kim, SJ Shin, SC Kim, S An, SY Rha, JB Ahn, BC Cho, HJ Choi, ...
Supportive Care in Cancer 21, 1751-1759, 2013
752013
Phase II clinical and exploratory biomarker study of dacomitinib in patients with recurrent and/or metastatic squamous cell carcinoma of head and neck
HS Kim, HJ Kwon, I Jung, MR Yun, MJ Ahn, BW Kang, JM Sun, SB Kim, ...
Clinical Cancer Research 21 (3), 544-552, 2015
702015
Efficacy and safety of atezolizumab plus bevacizumab in Korean patients with advanced hepatocellular carcinoma
J Cheon, C Yoo, JY Hong, HS Kim, DW Lee, MA Lee, JW Kim, I Kim, ...
Liver International 42 (3), 674-681, 2022
602022
Co-clinical trials demonstrate predictive biomarkers for dovitinib, an FGFR inhibitor, in lung squamous cell carcinoma
HR Kim, HN Kang, HS Shim, EY Kim, J Kim, DJ Kim, JG Lee, CY Lee, ...
Annals of Oncology 28 (6), 1250-1259, 2017
552017
BRCA mutational status shapes the stromal microenvironment of pancreatic cancer linking clusterin expression in cancer associated fibroblasts with HSF1 signaling
L Shaashua, A Ben-Shmuel, M Pevsner-Fischer, G Friedman, ...
Nature communications 13 (1), 6513, 2022
462022
Identification of somatic mutations in EGFR/KRAS/ALK-negative lung adenocarcinoma in never-smokers
JW Ahn, HS Kim, JK Yoon, H Jang, SM Han, S Eun, HS Shim, HJ Kim, ...
Genome medicine 6, 1-10, 2014
452014
A coding variant in FTO confers susceptibility to thiopurine-induced leukopenia in East Asian patients with IBD
HS Kim, JH Cheon, ES Jung, J Park, S Aum, SJ Park, S Eun, J Lee, ...
Gut 66 (11), 1926-1935, 2017
412017
ÇöÀç ½Ã½ºÅÛÀÌ ÀÛµ¿µÇÁö ¾Ê½À´Ï´Ù. ³ªÁß¿¡ ´Ù½Ã ½ÃµµÇØ ÁÖ¼¼¿ä.
ÇмúÀÚ·á 1–20